株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙SALE
市場調査レポート

医療用マイクロ流体の世界市場:2016〜2020年

Global Microfluidic Market for Healthcare Application 2016-2020

発行 TechNavio (Infiniti Research Ltd.) 商品コード 364942
出版日 ページ情報 英文 58 Pages
即納可能
価格
本日の銀行送金レート: 1USD=113.38円で換算しております。
Back to Top
医療用マイクロ流体の世界市場:2016〜2020年 Global Microfluidic Market for Healthcare Application 2016-2020
出版日: 2016年07月21日 ページ情報: 英文 58 Pages
概要

マイクロ流体技術は、少量の流体を扱う能力のあるもので、ミクロサイズの装置の研究開発に役立てられます。また、患者の健康状況をモニタリングして、疾患の早期発見や治療を確実にします。マイクロ流体装置の利点は、そのコンパクトサイズ、低い電力消費、コスト効率、変動性の高さなどがあります。世界の医療用マイクロ流体市場は、2016〜2020年にかけCA17.59%で拡大すると予測されています。

当レポートでは、世界の医療用マイクロ流体市場ついて調査し、市場の成長見通し、地域別動向、市場の動向と課題、主要ベンダーの競合動向などをまとめています。

第1章 エグゼクティブサマリー

第2章 当レポートの範囲

第3章 市場調査方法

第4章 イントロダクション

第5章 技術環境

  • マイクロ流体システム

第6章 市況

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第7章 医療用マイクロ流体の世界市場:用途別市場分類

  • エンドユーザー用途
  • マイクロ流体を用いた体外診断
  • マイクロ流体を用いた医薬品研究
  • マイクロ流体を用いたドラッグデリバリー装置

第8章 医療用マイクロ流体の世界市場:地域別分類

  • 地域分類
  • 南北アメリカ
  • 欧州・中東・アフリカ
  • アジア太平洋地域

第9章 医療用マイクロ流体の世界市場:促進因子

  • コンパクトサイズ
  • 生活習慣病の増大
  • 研究費の増加と政府の参画
  • 高齢者の急速な増加と年齢に関する疾患の増加
  • 処理量の高さと反応コストの低減

第10章 促進因子の影響

第11章 医療用マイクロ流体の世界市場:課題

  • 従来の医療機器の高い普及率
  • マイクロ流体バリューチェーンにおける企業の低い利益率
  • マイクロ流体に対する認識不足
  • 信頼性問題

第12章 促進因子と課題の影響

第13章 医療用マイクロ流体の世界市場:動向

第14章 ベンダー環境

  • 競合シナリオ

第15章 主要ベンダー

  • Abbott Laboratories
  • Agilent Technologies
  • Becton Dickinson
  • Bio-Rad Laboratories
  • RainDance Technologies
  • Roche Diagnostics
  • Siemens Healthcare
  • その他の注目すべきベンダー

第16章 ベンダーおよび投資家に対する提言

第17章 付録

第18章 Technavioについて

図表
  • Exhibit 01: Product offerings
  • Exhibit 02: Steps of a typical microfluidic process
  • Exhibit 03: Market segmentation of microfluidics in healthcare
  • Exhibit 04: Global microfluidic market for healthcare application 2016-2020 ($ billions)
  • Exhibit 05: Five forces analysis
  • Exhibit 06: Percentage segregation of microfluidics for application in healthcare sector 2015
  • Exhibit 07: Percentage segregation of microfluidics for application in healthcare sector 2020
  • Exhibit 08: Global microfluidic market for in-vitro diagnostics in healthcare 2015-2020 ($ billions)
  • Exhibit 09: Global microfluidic market in pharmaceutical research for healthcare 2015-2020 ($ billions)
  • Exhibit 10: Global microfluidic market in drug delivery devices for healthcare 2015-2020 ($ millions)
  • Exhibit 11: Geographical share in percentage 2015
  • Exhibit 12: Geographical share in percentage 2020
  • Exhibit 13: Global microfluidic market for healthcare application in Americas 2016-2020 ($ billions)
  • Exhibit 14: Global microfluidic market for healthcare application in EMEA 2015-2020 ($ billions)
  • Exhibit 15: Global microfluidic market for healthcare application in APAC 2015-2020 ($ millions)
  • Exhibit 16: Impact of drivers
  • Exhibit 17: Impact of drivers and challenges
  • Exhibit 18: Overview of major players in the global microfluidic market for healthcare application 2015
  • Exhibit 19: Recent developments: Abbott Laboratories
  • Exhibit 20: Sector performance
  • Exhibit 21: Capital expenditure
  • Exhibit 22: Segment performance
  • Exhibit 23: Capital expenditure
  • Exhibit 24: Siemens Healthcare: Business segmentation
  • Exhibit 25: Recent developments: Siemens Healthcare
  • Exhibit 26: Other prominent vendors
目次
Product Code: IRTNTR8681

About Microfluidics technology

Microfluidics technology deals with the research and development of micro-scale devices, which are capable of handling small amounts of fluids. These devices are used in the healthcare sector to dispense the exact volume of fluids for research, drug development, and drug delivery. Microfluidic devices can also be used to monitor patient health status, ensuring early detection and treatment of diseases. The advantages of these devices are their compact size, low power consumption, cost efficiency, and high functionality.

Technavio's analysts forecast the global microfluidic market for healthcare application to grow at a CAGR of 17.59% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global microfluidic market for healthcare application for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales and use of microfluidic devices and technology.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Microfluidic Market for Healthcare Application 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott Laboratories
  • Agilent Technologies
  • Becton Dickinson and Company
  • Bio-Rad Laboratories
  • RainDance Technologies
  • Roche Diagnostics
  • Siemens Healthcare GmbH

Other Prominent Vendors

  • Biocartis
  • Biofluidix
  • Cepheid
  • Danaher
  • Fluidigm
  • Great Basin
  • Life Technologies
  • Oxford Nanopore
  • PerkinElmer
  • Tear Lab
  • Thermo Fisher Scientific

Market driver

  • Rapid increase in elderly population and age-related diseases
  • For a full, detailed list, view our report

Market challenge

  • Low margins for companies in the microfluidic value chain
  • For a full, detailed list, view our report

Market trend

  • Use of paper-based microfluidic devices
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Report overview
  • Key vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Technology landscape

  • Microfluidic systems

PART 06: Market landscape

  • Industry overview
  • Market size and forecast
  • Five forces analysis

PART 07: Market segmentation by application

  • End-user applications of microfluidics in healthcare 2015
  • End-user applications of microfluidics in healthcare 2020
  • In-vitro diagnostics using microfluidics
  • Pharmaceutical research using microfluidics
  • Drug delivery devices using microfluidics

PART 08: Geographical segmentation

  • Regional segregation 2015
  • Regional segregation 2020
  • Americas
  • EMEA
  • APAC

PART 09: Market drivers

  • Compact size of microfluidic devices
  • Growth in lifestyle diseases
  • Increase in research funding and government participation
  • Rapid increase in elderly population and age-related diseases
  • Higher throughput and reduced reaction cost

PART 10: Impact of drivers

PART 11: Market challenges

  • High penetration of traditional healthcare equipment
  • Low margins for companies in the microfluidic value chain
  • Lack of awareness about microfluidics
  • Reliability issues

PART 12: Impact of drivers and challenges

PART 13: Market trends

  • Use of paper-based microfluidic devices
  • Growth in POC testing

PART 14: Vendor landscape

  • Competitive scenario

PART 15: Key vendors

  • Abbott Laboratories
  • Agilent Technologies
  • Becton Dickinson
  • Bio-Rad Laboratories
  • RainDance Technologies
  • Roche Diagnostics
  • Siemens Healthcare
  • Other prominent vendors

PART 16: Key recommendations for vendors and investors

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

Back to Top